What is Fullife?
Founded in 2019 and headquartered in India, Fullife operates at the intersection of health-tech and consumer nutrition. The company specializes in the development and manufacturing of high-quality nutrition products designed to meet the evolving needs of a health-conscious demographic. By leveraging advanced production methodologies, Fullife has established a robust market position, transitioning from a nascent startup to a significant player in the enterprise-level healthcare space. Its commitment to product integrity and scalable manufacturing has allowed it to capture substantial interest from major financial institutions looking to capitalize on the burgeoning wellness economy.
How much funding has Fullife raised?
Fullife has raised a total of $22M across 1 funding round:
Series C
$22M
Series C (2021): $22M with participation from Morgan Stanley
Key Investors in Fullife
Morgan Stanley
Morgan Stanley is a premier global financial services firm providing comprehensive investment banking, securities, and wealth management services to a diverse institutional and corporate client base.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Fullife?
With this major strategic investment, Fullife is well-positioned to accelerate its operational roadmap. The influx of capital will likely be directed toward enhancing supply chain efficiencies, expanding product distribution networks, and potentially exploring new international markets. As the company moves beyond its initial growth phase, the focus will shift toward sustaining long-term profitability and maintaining its competitive edge in the nutrition manufacturing sector. Investors will be closely monitoring the firm's ability to integrate these resources into its core business model to drive sustainable, enterprise-grade growth.
See full Fullife company page
